Skip to content

Evaluation of OCT Measurements

Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01806402
Enrollment
135
Registered
2013-03-07
Start date
2013-02-28
Completion date
2013-08-31
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assess Eye Measurements in Patients Having Retina Pathology or Glaucoma

Brief summary

The purpose of the study is to repeatability, reproducibility and agreement of eye measurements in retina and glaucoma patients.

Detailed description

The purpose of the study is to repeatability, reproducibility and agreement of eye measurements in retina and glaucoma patients using OCT technology. There will be a series of measurements acquired from one eye on at least 2 different OCT devices. All testing will be completed in one visit.

Interventions

None listed

Sponsors

Optovue
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion Criterea: * At least 18 years of age * Able and willing to provide consent * Willing to complete the required examinations and visits * Best corrected visual acuity equal or better than 20/100 * Retina subject must have clinical diagnosis of retinal pathology * Glaucoma subjects must have clinical diagnosis of glaucoma

Exclusion criteria

* Unable to complete the required examinations and visits * Poor OCT image quality as a result of media opacity, extreme refractive error or pathologies in the anterior segment * Confounding pathology requiring surgical treatment or medical intervention

Design outcomes

Primary

MeasureTime frame
Retina thicknessDay 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026